Four tables were not included in the published study, “Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection”.
Table 1, below, corresponded with data in Patients and Methods section under the subheads, Patients and Tumor Characteristics and Clinical Data Collection and the CONUT Score
Table 1.
Baseline characteristics of all patients
| Variable | Characteristics | Number | % |
| Gender | Men | 393 | 60 |
| Women | 265 | 40 | |
| Age (years) | < 50 | 437 | 66 |
| ≥ 50 | 221 | 34 | |
| BMI (kg/m2) | < 18.5 | 80 | 12 |
| 18.5 to 25.0 | 430 | 65 | |
| ≥ 25.0 | 148 | 23 | |
| Pathological types | Fibrosarcoma | 151 | 23 |
| Liposarcoma | 91 | 14 | |
| Undifferentiated pleomorphic sarcoma | 149 | 23 | |
| Leiomyosarcoma | 27 | 4 | |
| Synovial sarcoma | 77 | 12 | |
| Rhabdomyosarcoma | 38 | 6 | |
| Alveolar soft part sarcoma | 12 | 2 | |
| Epithelioid sarcoma | 15 | 2 | |
| Angiosarcoma | 13 | 2 | |
| Malignant peripheral nerve sheath tumor | 38 | 6 | |
| Mesenchymal chondrosarcoma | 20 | 3 | |
| Others | 27 | 4 | |
| Tumor size | < 5 cm | 322 | 49 |
| ≥ 5 cm | 336 | 51 | |
| Tumor site | Upper extremity | 82 | 13 |
| Lower extremity | 216 | 33 | |
| Thoracic/trunk/abdominal wall | 191 | 29 | |
| Intra-abdominal | 71 | 11 | |
| Head/neck | 80 | 12 | |
| Others* | 18 | 3 | |
| Tumor depth | Superficial | 235 | 36 |
| Deep | 423 | 64 | |
| Tumor grade | G1 | 130 | 20 |
| G2 | 304 | 46 | |
| G3 | 201 | 31 | |
| GX | 23 | 4 | |
| AJCC stage | IA | 88 | 13 |
| IB | 45 | 7 | |
| II | 233 | 35 | |
| IIIA | 132 | 20 | |
| IIIB | 75 | 11 | |
| IV | 12 | 2 | |
| Unknown | 73 | 11 | |
| NLR | < 2.51 | 453 | 69 |
| ≥ 2.51 | 205 | 31 | |
| PLR | < 164.5 | 516 | 78 |
| ≥ 164.5 | 142 | 22 | |
| HS-mGPS | 0 | 311 | 62 |
| 1-2 | 194 | 38 | |
| CONUT | 0 | 227 | 35 |
| 1 | 208 | 32 | |
| 2-12 | 223 | 34 | |
| Albumin score | 0 | 606 | 92 |
| 2/4/6 | 52 | 8 | |
| Total lymphocyte score | 0 | 327 | 50 |
| 1 | 253 | 38 | |
| 2/3 | 78 | 12 | |
| Total cholesterol score | 0 | 477 | 73 |
| 1 | 118 | 18 | |
| 2/3 | 63 | 10 | |
| Endpoint | Alive | 484 | 74 |
| Dead | 174 | 26 | |
| Recurrence | Yes | 250 | 38 |
| No | 408 | 62 | |
| Metastasis | Yes | 94 | 14 |
| No | 564 | 86 | |
| Adjuvant therapy | None | 467 | 71 |
| Chemotherapy | 41 | 6 | |
| Radiotherapy | 44 | 7 | |
| Combined chemoradiotherapy | 11 | 2 | |
| Unknown | 95 | 14 |
Including the perineum, crissum, pleural cavity, and pulmonary system
HS-mGPS = high-sensitivity modified Glasgow prognostic score
Table 2, below, corresponded with data in the Results section under the subhead, Correlation Between the CONUT Score and Clinicopathologic Characteristics.
Table 2.
Relationships between the CONUT score and patient characteristics
| Characteristics | CONUT score | p value | OR (95% CI) | |
| Low (n = 435), (%) | High (n = 223), (%) | |||
| Gender | 0.761 | |||
| Men | 177 (41) | 88 (40) | ||
| Women | 258 (59) | 135 (60) | 1.05 (0.76-1.46) | |
| Age at operation (years) | 0.848 | |||
| < 50 | 290 (67) | 147 (66) | ||
| ≥ 50 | 145 (33) | 76 (34) | 1.03 (0.74-1.45) | |
| Tumor diameter (cm) | 0.020 | |||
| < 5 cm | 227 (52) | 95 (43) | ||
| ≥ 5 cm | 208 (48) | 128 (57) | 1.47 (1.06-2.04) | |
| Tumor depth | 0.004 | |||
| Superficial | 172 (40) | 63 (28) | ||
| Deep | 263 (60) | 160 (72) | 1.66 (1.17-2.36) | |
| Tumor grade | 0.001 | |||
| G1 | 99 (23) | 31 (14) | ||
| G2 | 209 (48) | 95 (43) | 1.45 (0.91-2.32) | |
| G3 | 112 (26) | 89 (40) | 2.54 (1.56-4.14) | |
| Missing data | 15 (3) | 8 (3) | 1.70 (0.66-4.40) | |
| AJCC stage | < 0.001 | |||
| IA + IB | 102 (23) | 31 (14) | ||
| II | 161 (37) | 72 (33) | 1.47 (0.90-2.40) | |
| II + IV | 140 (33) | 79 (35) | 1.86 (1.14-3.02) | |
| Unknown | 32 (7) | 41 (18) | 4.22 (2.29-7.78) | |
| NLR | < 0.001 | |||
| < 2.51 | 354 (81) | 99 (44) | ||
| ≥ 2.51 | 81 (19) | 124 (56) | 5.48 (3.83-7.83) | |
| PLR | < 0.001 | |||
| < 164.5 | 390 (90) | 126 (57) | ||
| ≥ 164.5 | 45 (10) | 97 (43) | 6.67 (4.44-10.02) | |
| Endpoint | < 0.001 | |||
| Alive | 352 (81) | 132 (59) | ||
| Dead | 83 (19) | 91 (41) | 2.92 (2.04-4.18) | |
| Recurrence | < 0.001 | |||
| No | 294 (68) | 114 (51) | ||
| Yes | 141 (32) | 109 (49) | 1.99 (1.43-2.78) | |
| Metastasis | < 0.001 | |||
| No | 391 (90) | 173 (78) | ||
| Yes | 44 (10) | 50 (22) | 2.57 (1.65-4.00) | |
Tables 3 and 4, both below, corresponded with data in the Results section under the subhead, Survival Analysis.
Table 3.
Multivariate analyses of risk factors associated with OS in patients with STS
| Variable | HR (95% CI) | p value |
| Tumor depth | 0.017 | |
| Superficial | 1 (reference) | |
| Deep | 1.71 (1.10-2.65) | |
| Tumor grade | < 0.001 | |
| G1 | 1 (reference) | |
| G2 | 3.19 (0.46-22.06) | |
| G3 | 8.97 (1.28-62.73) | |
| AJCC stage | 0.009 | |
| IA + IB | 1 (reference) | |
| II | 0.38 (0.06-2.47) | |
| III + IV | 0.69 (0.11-4.34) | |
| CONUT score | < 0.001 | |
| Low | 1 (reference) | |
| High | 1.86 (1.32-2.61) |
Table 4.
Multivariate analyses of risk factors associated with DFS in patients with STS
| Variable | HR (95% CI) | p value |
| Tumor depth | < 0.001 | |
| Superficial | 1 (reference) | |
| Deep | 2.03 (1.50-2.73) | |
| Tumor grade | < 0.001 | |
| G1 | 1 (reference) | |
| G2 | 1.94 (1.28-2.96) | 0.002 |
| G3 | 2.71 (1.75-4.20) | < 0.001 |
| CONUT score | < 0.001 | |
| Low | 1 (reference) | |
| High | 1.63 (1.26-2.11) |
CORR apologizes for the error.
Supplementary Material
Footnotes
Erratum to: Clin Orthop Relat Res DOI: 10.1097/CORR.0000000000000767.
The online version of this article can be found under DOI: 10.1097/CORR.0000000000000767.
Contributor Information
Yao Liang, Email: liangyao@sysucc.org.cn.
Tao Hou, Email: houtao0202@163.com.
Yi Que, Email: queyi@sysucc.org.cn.
Baiwei Zhao, Email: zhaobw@sysucc.org.cn.
Wei Xiao, Email: xiaowei@sysucc.org.cn.
Xing Zhang, Email: zhangxing@sysucc.org.cn.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.